Available EXPANDED_ACCESS NCT06188975
Expanded Access to ABBV-CLS-484
Sponsor: Calico Life Sciences LLC
Conditions
Advanced Solid Tumor Cancer
Interventions
DRUG: ABBV-CLS-484
Updated 3 times since 2024 Last updated: Dec 18, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06188975, this observational or N/A phase trial focuses on Advanced Solid Tumor Cancer and remains ongoing. Sponsored by Calico Life Sciences LLC, it has been updated 3 times since 2026, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Available
-
Jul 2024 — Sep 2024 [monthly]
Available
-
Feb 2024 — Jul 2024 [monthly]
Available
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Calico Life Sciences LLC
Data source: Calico Life Sciences LLC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.